Cargando…

Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems

New generation vaccines, based on isolated antigens, are safer than traditional ones, comprising the whole pathogen. However, major part of purified antigens has weak immunogenicity. Therefore, elaboration of new adjuvants, more effective and safe, is an urgent problem of vaccinology. Tubular immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanina, Nina, Chopenko, Natalia, Mazeika, Andrey, Kostetsky, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541816/
https://www.ncbi.nlm.nih.gov/pubmed/28808657
http://dx.doi.org/10.1155/2017/4389525
_version_ 1783254883745398784
author Sanina, Nina
Chopenko, Natalia
Mazeika, Andrey
Kostetsky, Eduard
author_facet Sanina, Nina
Chopenko, Natalia
Mazeika, Andrey
Kostetsky, Eduard
author_sort Sanina, Nina
collection PubMed
description New generation vaccines, based on isolated antigens, are safer than traditional ones, comprising the whole pathogen. However, major part of purified antigens has weak immunogenicity. Therefore, elaboration of new adjuvants, more effective and safe, is an urgent problem of vaccinology. Tubular immunostimulating complexes (TI-complexes) are a new type of nanoparticulate antigen delivery systems with adjuvant activity. TI-complexes consist of cholesterol and compounds isolated from marine hydrobionts: cucumarioside A2-2 (CDA) from Cucumaria japonica and monogalactosyldiacylglycerol (MGDG) from marine algae or seagrass. These components were selected due to immunomodulatory and other biological activities. Glycolipid MGDG from marine macrophytes comprises a high level of polyunsaturated fatty acids (PUFAs), which demonstrate immunomodulatory properties. CDA is a well-characterized individual compound capable of forming stable complex with cholesterol. Such complexes do not possess hemolytic activity. Ultralow doses of cucumariosides stimulate cell as well as humoral immunity. Therefore, TI-complexes comprising biologically active components turned out to be more effective than the strongest adjuvants: immunostimulating complexes (ISCOMs) and complete Freund's adjuvant. In the present review, we discuss results published in series of our articles on elaboration, qualitative and quantitative composition, ultrastructure, and immunostimulating activity of TI-complexes. The review allows immersion in the history of creating TI-complexes.
format Online
Article
Text
id pubmed-5541816
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-55418162017-08-14 Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems Sanina, Nina Chopenko, Natalia Mazeika, Andrey Kostetsky, Eduard Biomed Res Int Review Article New generation vaccines, based on isolated antigens, are safer than traditional ones, comprising the whole pathogen. However, major part of purified antigens has weak immunogenicity. Therefore, elaboration of new adjuvants, more effective and safe, is an urgent problem of vaccinology. Tubular immunostimulating complexes (TI-complexes) are a new type of nanoparticulate antigen delivery systems with adjuvant activity. TI-complexes consist of cholesterol and compounds isolated from marine hydrobionts: cucumarioside A2-2 (CDA) from Cucumaria japonica and monogalactosyldiacylglycerol (MGDG) from marine algae or seagrass. These components were selected due to immunomodulatory and other biological activities. Glycolipid MGDG from marine macrophytes comprises a high level of polyunsaturated fatty acids (PUFAs), which demonstrate immunomodulatory properties. CDA is a well-characterized individual compound capable of forming stable complex with cholesterol. Such complexes do not possess hemolytic activity. Ultralow doses of cucumariosides stimulate cell as well as humoral immunity. Therefore, TI-complexes comprising biologically active components turned out to be more effective than the strongest adjuvants: immunostimulating complexes (ISCOMs) and complete Freund's adjuvant. In the present review, we discuss results published in series of our articles on elaboration, qualitative and quantitative composition, ultrastructure, and immunostimulating activity of TI-complexes. The review allows immersion in the history of creating TI-complexes. Hindawi 2017 2017-07-20 /pmc/articles/PMC5541816/ /pubmed/28808657 http://dx.doi.org/10.1155/2017/4389525 Text en Copyright © 2017 Nina Sanina et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Sanina, Nina
Chopenko, Natalia
Mazeika, Andrey
Kostetsky, Eduard
Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems
title Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems
title_full Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems
title_fullStr Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems
title_full_unstemmed Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems
title_short Nanoparticulate Tubular Immunostimulating Complexes: Novel Formulation of Effective Adjuvants and Antigen Delivery Systems
title_sort nanoparticulate tubular immunostimulating complexes: novel formulation of effective adjuvants and antigen delivery systems
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541816/
https://www.ncbi.nlm.nih.gov/pubmed/28808657
http://dx.doi.org/10.1155/2017/4389525
work_keys_str_mv AT saninanina nanoparticulatetubularimmunostimulatingcomplexesnovelformulationofeffectiveadjuvantsandantigendeliverysystems
AT chopenkonatalia nanoparticulatetubularimmunostimulatingcomplexesnovelformulationofeffectiveadjuvantsandantigendeliverysystems
AT mazeikaandrey nanoparticulatetubularimmunostimulatingcomplexesnovelformulationofeffectiveadjuvantsandantigendeliverysystems
AT kostetskyeduard nanoparticulatetubularimmunostimulatingcomplexesnovelformulationofeffectiveadjuvantsandantigendeliverysystems